The Valley Desk

Clinical trial reportCancerPublished

Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names GSK. Affiliation source

Institution
GSK

Publication record

Type
Clinical trial report
Venue
Cancer
Published
Subject terms
Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Antineoplastic Combined Chemotherapy Protocols; Adult; Aged; Aged, 80 and over; Middle Aged; Female; Male; Antibodies, Monoclonal, Humanized; Safety
PubMed ID
38630908
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal